{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-005711","form_type":"8-K","ticker":"RNXT","cik":"0001574094","company_name":"RenovoRx, Inc.","filed_at":"2024-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.667396+00:00","generated_at":"2026-06-06T04:49:49.224898+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"RenovoRx CFO James Ahlers resigns; VP Kocak named Principal Accounting Officer with $235K salary","bullets":["James Ahlers resigned as CFO effective Feb 5, 2024, for personal reasons; no disagreement with the company.","Ronald B. Kocak, previously VP and Controller, appointed VP, Controller and Principal Accounting Officer effective Feb 9, 2024.","Kocak receives $235,000 base salary, up to 35% bonus, and option for 15,000 shares at $1.56, vesting over 4 years with double trigger.","Kocak will serve as principal financial and accounting officer; CFO position remains unfilled."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-005711","json":"https://secwatch.observer/filing/0001493152-24-005711.json","markdown":"https://secwatch.observer/filing/0001493152-24-005711.md","text":"https://secwatch.observer/filing/0001493152-24-005711.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574094/000149315224005711/0001493152-24-005711-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574094/000149315224005711/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T04:49:49.224898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"22f44692c0","claim":"Ronald B. Kocak was appointed as Vice President, Controller and Principal Accounting Officer at RenovoRx, Inc..","evidence_excerpt":"On February 8, 2024, the Company’s board of directors (the “Board”), at the recommendation of the audit and compensation committees of the Board, appointed Ronald B. Kocak, CPA, CGMA, the Company’s current Vice President and Controller, to the position of Vice President, Controller and Principal Accounting Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1574094/000149315224005711/0001493152-24-005711-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Vice President, Controller and Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"46e321e7cc","claim":"James Ahlers resigned as Chief Financial Officer at RenovoRx, Inc..","evidence_excerpt":"On February 5, 2024, James Ahlers provided written notice to RenovoRx, Inc. (the “Company”) of his resignation as the Company’s Chief Financial Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1574094/000149315224005711/0001493152-24-005711-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}